Literature DB >> 10912917

The extent of neurofibrillary pathology in perforant pathway neurons is the key determinant of dementia in the very old.

F García-Sierra1, J J Hauw, C Duyckaerts, C M Wischik, J Luna-Muñoz, R Mena.   

Abstract

Neurofibrillary pathology as found in Alzheimer's disease (AD) is also found in the normal elderly, suggesting that these changes may be part of the aging process. In this study, we assessed the densities and distribution of structures recognized by the monoclonal antibody (mAb) to phosphorylated tau (AT8) in the hippocampal formation and medial temporal isocortex of 19 centenarians. Of these, 4 cases were demented and 15 non-demented. AT8 immunoreactivity correlated with the global deterioration scale (GDS). The density of both intraneuronal neurofibrillary tangles (I-NFTs) and neuritic clusters (NCs) significantly correlated with the GDS in the layer II of the entorhinal cortex (r = 0.66, P = 0.005 and r= 0.611, P = 0.01, respectively). Density of I-NFTs in the subiculum (r = 0.491; P = 0.034) also correlated significantly. No other area was found to be statistically significant. Importantly, no correlation was found when demented and non-demented centenarian cases were analyzed separately, suggesting that the difference marks a fundamental shift between AD and non-demented individuals. This assertion is supported by the significantly higher densities of I-NFTs and NCs in the transentorhinal (P = 0.043 and P = 0.011, respectively) and layer II of the entorhinal cortex (P = 0.02 and P = 0.007, respectively), and I-NFTs in the subiculum (P < 0.001) and CAI (P = 0.011) in the demented group when compared with the non-demented cases. Granular diffuse deposits, an early stage parameter of the neurofibrillary pathology involving accumulation of non-fibrillar abnormally phosphorylated tau protein did not correlate with the GDS or between the two groups studied. This study, combining morphometric and confocal analyses, not only provides further evidence that, in the brains of patients with AD, the perforant pathway is highly sensitive to tau pathology but also that involvement is distinct from the changes of normal aging, even of the oldest old.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10912917     DOI: 10.1007/s004010051189

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  26 in total

1.  Focal expression of mutated tau in entorhinal cortex neurons of rats impairs spatial working memory.

Authors:  Julio J Ramirez; Winona E Poulton; Erik Knelson; Cole Barton; Michael A King; Ronald L Klein
Journal:  Behav Brain Res       Date:  2010-08-19       Impact factor: 3.332

2.  Challenges in the conduct of disease-modifying trials in AD: practical experience from a phase 2 trial of Tau-aggregation inhibitor therapy.

Authors:  C Wischik; R Staff
Journal:  J Nutr Health Aging       Date:  2009-04       Impact factor: 4.075

3.  MicroRNA in Situ Hybridization in the Human Entorhinal and Transentorhinal Cortex.

Authors:  Peter T Nelson; James Dimayuga; Bernard R Wilfred
Journal:  Front Hum Neurosci       Date:  2010-02-22       Impact factor: 3.169

4.  Clinico-Neuropathological Findings in the Oldest Old from the Georgia Centenarian Study.

Authors:  Jirayu Tanprasertsuk; Elizabeth J Johnson; Mary Ann Johnson; Leonard W Poon; Peter T Nelson; Adam Davey; Peter Martin; Aron K Barbey; Kathryn Barger; Xiang-Dong Wang; Tammy M Scott
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

Review 5.  Intrinsically disordered proteins in the neurodegenerative processes: formation of tau protein paired helical filaments and their analysis.

Authors:  Rostislav Skrabana; Jozef Sevcik; Michal Novak
Journal:  Cell Mol Neurobiol       Date:  2006-06-16       Impact factor: 5.046

6.  Comparative quantitative study of 'signature' pathological lesions in the hippocampus and adjacent gyri of 12 neurodegenerative disorders.

Authors:  Richard A Armstrong; Nigel J Cairns
Journal:  J Neural Transm (Vienna)       Date:  2015-05-01       Impact factor: 3.575

7.  Functional implications of hippocampal degeneration in early Alzheimer's disease: a combined DTI and PET study.

Authors:  Igor Yakushev; Matthias Schreckenberger; Matthias J Müller; Ingrid Schermuly; Paul Cumming; Peter Stoeter; Alex Gerhard; Andreas Fellgiebel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-07-27       Impact factor: 9.236

8.  The alternative splicing of the apolipoprotein E gene is unperturbed in the brains of Alzheimer's disease patients.

Authors:  James D Mills; Pamela J Sheahan; Donna Lai; Jillian J Kril; Michael Janitz; Greg T Sutherland
Journal:  Mol Biol Rep       Date:  2014-07-05       Impact factor: 2.316

9.  Subicular dendritic arborization in Alzheimer's disease correlates with neurofibrillary tangle density.

Authors:  Eric Falke; Jonathan Nissanov; Thomas W Mitchell; David A Bennett; John Q Trojanowski; Steven E Arnold
Journal:  Am J Pathol       Date:  2003-10       Impact factor: 4.307

10.  Brain pathologies in extreme old age.

Authors:  Janna H Neltner; Erin L Abner; Gregory A Jicha; Frederick A Schmitt; Ela Patel; Leonard W Poon; Gearing Marla; Robert C Green; Adam Davey; Mary Ann Johnson; S Michal Jazwinski; Sangkyu Kim; Daron Davis; John L Woodard; Richard J Kryscio; Linda J Van Eldik; Peter T Nelson
Journal:  Neurobiol Aging       Date:  2015-10-19       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.